Keywords: InterMune, Esbriet, France, Transparency Commission, Pulmonary fibrosis

French Transparency Commission issues favorable opinion on Esbriet

Article | 10 April 2012

Print This

There was good news last week for USA-based InterMune (Nasdaq: ITMN) when the Transparency Commission (CT: Commission de Transparence) of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in